Background and indications for Haemophilus influenzae type b vaccines consisting of capsular antigen coupled to protein carriers.
Anderson
P W
PW
Department of Pediatrics, University of Rochester, School of Medicine and Dentistry, N.Y.
Stein
E C
EC
Insel
R A
RA
D000328:Adult; D000367:Age Factors; D000907:Antibodies, Bacterial / Q000096:biosynthesis; D000942:Antigens, Bacterial / Q000008:administration & dosage / Q000276:immunology; D001428:Bacterial Vaccines / Q000276:immunology; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004168:Diphtheria Toxoid / Q000276:immunology; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae / Q000276:immunology*; D006801:Humans; D007223:Infant; D008583:Meningitis, Haemophilus / Q000517:prevention & control*; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage / Q000276:immunology; D011506:Proteins / Q000276:immunology; D013745:Tetanus Toxoid / Q000276:immunology; D014612:Vaccines / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D004168:Diphtheria Toxoid; D018073:Haemophilus Vaccines; C055753:Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate; C052180:Haemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugate; D011135:Polysaccharides, Bacterial; D011506:Proteins; D013745:Tetanus Toxoid; D014612:Vaccines; D014614:Vaccines, Synthetic